Cas:149068-60-0 1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene manufacturer & supplier

Chemical Name:1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene

CAS.NO:149068-60-0

Synonyms:Benzene,1-bromo-4-(2-propynyloxy);1-Bromo-4-(3,3,4,4,5,5,5-heptafluoro-2,2-bis-trifluoromethylpentyl)benzene;1-bromo-4-(prop-2-yn-1-yloxy)benzene;3-(4-bromophenoxy)prop-1yne;propargyl para-bromophenyl ether;(4-bromo-phenyl)-prop-2-ynyl ether;1-bromo-4-(2-trifluoromethoxyethyl)benzene;1-bromo-4-(2-propynyloxy)benzene;4-[3,3,4,4,5,5,5-heptafluoro-2,2-bis(trifluoromethyl)pentyl]-1-bromobenzene;1-bromo-4-prop-2-ynyloxybenzene;(4-Brom-phenyl)-prop-2-inyl-aether

Molecular Formula:C₁₃H₆BrF₁₃

Molecular Weight:489.07000

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:487.94500

LogP:6.93550

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Benzene,1-bromo-4-(2-propynyloxy) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-Brom-phenyl)-prop-2-inyl-aether physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-[3,3,4,4,5,5,5-heptafluoro-2,2-bis(trifluoromethyl)pentyl]-1-bromobenzene Use and application,1-bromo-4-(2-propynyloxy)benzene technical grade,usp/ep/jp grade.

Related News: Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. 1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene manufacturer Analysts at Jefferies, meanwhile, said the FDA accelerated approval for Aduhelm, which was based on a surrogate endpoint of amyloid beta plaque reduction (and not clinical benefit) “has implications for ongoing AD studies,” most notably, it reckons, for Roche’s phase 3 GRADUATE test for its anti-amyloid-beta candidate gantenerumab, “as a much lower hurdle than demonstrating clear cognitive benefit” has now become precedent. Jefferies, still cautious, said it remains “unclear what stance FDA may take for the field if GRADUATE fails on cognition despite significant Abeta reductions,” but says it’s probably not going to revive Roche-AC Immune’s anti-amyloid-beta candidate crenezumab, which saw its late-stage CREAD trials discontinued for futility but which is currently in an Alzheimer’s prevention study. 1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene supplier The vaccine significantly reduced — by 58% — the accumulation of neurofilament light chain in the blood. This is an important biomarker of neurodegenerative diseases, Novak said — damaged nerve cells release the substance, which leaks into the blood. 1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene vendor It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation. 1-bromo-4-(1h,1h-perfluoro-2,2-dimethylpentyl)benzene factory It has reserves in the direction of APIs and intermediates for lowering blood lipids, lowering blood sugar and anticoagulation.